• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧与浸润免疫细胞增加以及肌层浸润性膀胱癌的抗肿瘤和免疫抑制信号相关。

Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.

机构信息

Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.

Computational Biology Support, CRUK Manchester Institute, Alderley Park SK10 4TG, UK.

出版信息

Int J Mol Sci. 2023 May 18;24(10):8956. doi: 10.3390/ijms24108956.

DOI:10.3390/ijms24108956
PMID:37240301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219458/
Abstract

Hypoxia and a suppressive tumour microenvironment (TME) are both independent negative prognostic factors for muscle-invasive bladder cancer (MIBC) that contribute to treatment resistance. Hypoxia has been shown to induce an immune suppressive TME by recruiting myeloid cells that inhibit anti-tumour T cell responses. Recent transcriptomic analyses show hypoxia increases suppressive and anti-tumour immune signalling and infiltrates in bladder cancer. This study sought to investigate the relationship between hypoxia-inducible factor (HIF)-1 and -2, hypoxia, and immune signalling and infiltrates in MIBC. ChIP-seq was performed to identify HIF1α, HIF2α, and HIF1β binding in the genome of the MIBC cell line T24 cultured in 1% and 0.1% oxygen for 24 h. Microarray data from four MIBC cell lines (T24, J82, UMUC3, and HT1376) cultured under 1%, 0.2%, and 0.1% oxygen for 24 h were used. Differences in the immune contexture between high- and low-hypoxia tumours were investigated using in silico analyses of two bladder cancer cohorts (BCON and TCGA) filtered to only include MIBC cases. GO and GSEA were used with the R packages "limma" and "fgsea". Immune deconvolution was performed using ImSig and TIMER algorithms. RStudio was used for all analyses. Under hypoxia, HIF1α and HIF2α bound to ~11.5-13.5% and ~4.5-7.5% of immune-related genes, respectively (1-0.1% O). HIF1α and HIF2α both bound to genes associated with T cell activation and differentiation signalling pathways. HIF1α and HIF2α had distinct roles in immune-related signalling. HIF1 was associated with interferon production specifically, whilst HIF2 was associated with generic cytokine signalling as well as humoral and toll-like receptor immune responses. Neutrophil and myeloid cell signalling was enriched under hypoxia, alongside hallmark pathways associated with Tregs and macrophages. High-hypoxia MIBC tumours had increased expression of both suppressive and anti-tumour immune gene signatures and were associated with increased immune infiltrates. Overall, hypoxia is associated with increased inflammation for both suppressive and anti-tumour-related immune signalling and immune infiltrates, as seen in vitro and in situ using MIBC patient tumours.

摘要

缺氧和抑制性肿瘤微环境(TME)都是浸润性膀胱癌(MIBC)的独立负预后因素,导致治疗耐药。缺氧已被证明通过招募抑制抗肿瘤 T 细胞反应的髓样细胞来诱导免疫抑制性 TME。最近的转录组分析显示,缺氧增加了膀胱癌中的抑制性和抗肿瘤免疫信号和浸润。本研究旨在探讨 MIBC 中缺氧诱导因子(HIF)-1 和 -2、缺氧与免疫信号和浸润之间的关系。ChIP-seq 用于鉴定 MIBC 细胞系 T24 在 1%和 0.1%氧气中培养 24 小时时 HIF1α、HIF2α 和 HIF1β 在基因组中的结合。使用在 1%、0.2%和 0.1%氧气中培养 24 小时的四个 MIBC 细胞系(T24、J82、UMUC3 和 HT1376)的微阵列数据。使用两个膀胱癌队列(BCON 和 TCGA)的计算分析研究高氧和低氧肿瘤之间免疫结构的差异,该队列经过过滤仅包括 MIBC 病例。使用 R 包“limma”和“fgsea”进行 GO 和 GSEA。使用 ImSig 和 TIMER 算法进行免疫去卷积。所有分析均使用 RStudio 进行。在缺氧条件下,HIF1α 和 HIF2α 分别结合约 11.5-13.5%和 4.5-7.5%的免疫相关基因(1-0.1%O)。HIF1α 和 HIF2α 都结合到与 T 细胞激活和分化信号通路相关的基因上。HIF1α 和 HIF2α 在免疫相关信号中具有不同的作用。HIF1 与干扰素的产生特异性相关,而 HIF2 与通用细胞因子信号以及体液和 Toll 样受体免疫反应相关。缺氧时,中性粒细胞和髓样细胞信号被富集,同时与 Treg 和巨噬细胞相关的标志性途径也被富集。高氧 MIBC 肿瘤中抑制性和抗肿瘤免疫基因特征的表达增加,与免疫浸润增加相关。总的来说,缺氧与抑制性和抗肿瘤相关免疫信号和免疫浸润的炎症增加有关,这在体外和 MIBC 患者肿瘤的原位观察中都可以看到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/c747f93ff5ad/ijms-24-08956-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/62fb0291add8/ijms-24-08956-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/a3eef46e8a0e/ijms-24-08956-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/4ce866ceaf14/ijms-24-08956-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/c747f93ff5ad/ijms-24-08956-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/62fb0291add8/ijms-24-08956-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/a3eef46e8a0e/ijms-24-08956-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/4ce866ceaf14/ijms-24-08956-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04d6/10219458/c747f93ff5ad/ijms-24-08956-g004.jpg

相似文献

1
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.缺氧与浸润免疫细胞增加以及肌层浸润性膀胱癌的抗肿瘤和免疫抑制信号相关。
Int J Mol Sci. 2023 May 18;24(10):8956. doi: 10.3390/ijms24108956.
2
The effect of hypoxia on PD-L1 expression in bladder cancer.缺氧对膀胱癌中 PD-L1 表达的影响。
BMC Cancer. 2021 Nov 25;21(1):1271. doi: 10.1186/s12885-021-09009-7.
3
Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.多组学分析揭示了 IGF2BP3/SPHK1 信号在肌层浸润性膀胱癌肿瘤干细胞中对预后和免疫治疗反应的预测价值。
J Transl Med. 2024 Oct 4;22(1):900. doi: 10.1186/s12967-024-05685-8.
4
Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.增强子作为缺氧诱导因子 (HIF) 和其他转录因子在缺氧转录反应中的整合子。
Cell Signal. 2013 Sep;25(9):1895-903. doi: 10.1016/j.cellsig.2013.05.018. Epub 2013 May 21.
5
Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer.纤连蛋白 1:预测肌肉浸润性膀胱癌免疫治疗反应的生物标志物。
Arch Esp Urol. 2023 Feb;76(1):70-83. doi: 10.56434/j.arch.esp.urol.20237601.7.
6
STAT3 or USF2 contributes to HIF target gene specificity.STAT3 或 USF2 有助于 HIF 靶基因的特异性。
PLoS One. 2013 Aug 21;8(8):e72358. doi: 10.1371/journal.pone.0072358. eCollection 2013.
7
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.缺氧诱导因子在肿瘤微环境免疫反应调控中的作用
Immunology. 2014 Dec;143(4):512-9. doi: 10.1111/imm.12380.
8
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer.TIGIT 和 PD-1 表达图谱预测辅助化疗和 PD-L1 阻断在肌层浸润性膀胱癌中的反应。
Br J Cancer. 2022 May;126(9):1310-1317. doi: 10.1038/s41416-022-01703-y. Epub 2022 Jan 17.
9
Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).肿瘤微环境(TME)特征可鉴定肌层浸润性膀胱癌(MIBC)的预后和免疫治疗反应。
Cancer Immunol Immunother. 2021 Jan;70(1):1-18. doi: 10.1007/s00262-020-02649-x. Epub 2020 Jul 2.
10
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.可切除非小细胞肺癌中缺氧诱导因子1α和2α与肿瘤血管生成/分子特征及生存的关系
Br J Cancer. 2001 Sep 14;85(6):881-90. doi: 10.1054/bjoc.2001.2018.

引用本文的文献

1
Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression.缺氧诱导的M2巨噬细胞产生的骨桥蛋白通过调节EGR3/ISG15信号通路和RIG-I表达促进骨肉瘤进展。
J Transl Med. 2025 Aug 21;23(1):950. doi: 10.1186/s12967-025-06936-y.
2
Fractalkine/CX3CL1 and macrophage inflammatory protein- 1β/CCL4 activity in the rat ovary with induced ovarian hyperstimulation.诱导卵巢过度刺激大鼠卵巢中趋化因子/ CX3CL1和巨噬细胞炎性蛋白-1β/ CCL4的活性
Turk J Obstet Gynecol. 2024 Dec 12;21(4):220-226. doi: 10.4274/tjod.galenos.2024.72002.
3

本文引用的文献

1
Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patients.量化转录因子活性、突变和 microRNAs 对癌症患者 CD274 表达的贡献。
Sci Rep. 2022 Mar 14;12(1):4374. doi: 10.1038/s41598-022-08356-0.
2
The effect of hypoxia on PD-L1 expression in bladder cancer.缺氧对膀胱癌中 PD-L1 表达的影响。
BMC Cancer. 2021 Nov 25;21(1):1271. doi: 10.1186/s12885-021-09009-7.
3
A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
Identification of potential immune-related genes and infiltrations in temporomandibular joint osteoarthritis.
颞下颌关节骨关节炎中潜在免疫相关基因及浸润情况的鉴定
Ann Med Surg (Lond). 2024 Oct 23;86(12):7135-7146. doi: 10.1097/MS9.0000000000002682. eCollection 2024 Dec.
4
Emerging roles of MITF as a crucial regulator of immunity.MITF 作为免疫关键调节因子的新作用。
Exp Mol Med. 2024 Feb;56(2):311-318. doi: 10.1038/s12276-024-01175-5. Epub 2024 Feb 13.
一种稳健的低氧风险评分可预测膀胱癌的临床结局和肿瘤微环境免疫特征。
Front Immunol. 2021 Aug 13;12:725223. doi: 10.3389/fimmu.2021.725223. eCollection 2021.
4
Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.用于预测膀胱癌患者生存结局的缺氧相关特征的开发与验证
Front Genet. 2021 May 26;12:670384. doi: 10.3389/fgene.2021.670384. eCollection 2021.
5
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer.用于预测膀胱癌预后和免疫微环境的缺氧相关特征的鉴定
Front Mol Biosci. 2021 May 7;8:613359. doi: 10.3389/fmolb.2021.613359. eCollection 2021.
6
Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399).根治性放化疗联合生物标志物分层的缺氧修饰治疗的长期结果:膀胱癌 Carbogen 烟酰胺(BCON)3 期随机试验(ISRCTN45938399)的 10 年更新。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1407-1415. doi: 10.1016/j.ijrobp.2021.03.001. Epub 2021 Mar 6.
7
Roles of IFN-γ in tumor progression and regression: a review.γ干扰素在肿瘤进展与消退中的作用:综述
Biomark Res. 2020 Sep 29;8:49. doi: 10.1186/s40364-020-00228-x. eCollection 2020.
8
Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4 T Cell Populations.IL-2-STAT5 信号在效应器和调节性 CD4 T 细胞群体中的动态作用。
J Immunol. 2020 Oct 1;205(7):1721-1730. doi: 10.4049/jimmunol.2000612.
9
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers.HIF1A 的表达与人类癌症中肿瘤免疫和基质特征的增加以及侵袭性表型相关。
Cell Oncol (Dordr). 2020 Oct;43(5):877-888. doi: 10.1007/s13402-020-00534-4. Epub 2020 Jun 1.
10
The TNF Paradox in Cancer Progression and Immunotherapy.癌症进展与免疫治疗中的肿瘤坏死因子悖论
Front Immunol. 2019 Jul 31;10:1818. doi: 10.3389/fimmu.2019.01818. eCollection 2019.